Contract Notice Detail

Summary Information Summary Information Base Total Price: 254,825.900000 Euro   Forbid offers above base price:   Request Reference: PH-111006624   Request Name: AQUISIÇÃO DE MEDICAMENTOS EXCLUSIVOS DA EMPRESA SANOFI PRODUTOS FARMACEUTICOS, S.A 2024   Phase: Tendering Phase State: Awarded Description: AQUISIÇÃO DE MEDICAMENTOS EXCLUSIVOS DA EMPRESA SANOFI PRODUTOS FARMACEUTICOS, S.A 2024   Procedure Type: VortalGOV - Direct Award (ECP)   Object of the Contract Object of the Contract Type of Contract: Supplies Acquisition   Main Object CPV Main Category: Estrada do Forte do Alto do Duque 1449-005 Lisboa PORTUGAL   CPV Main Vocabulary 33600000-6 - Pharmaceutical products   CPV Supplementary Vocabulary   Additional Classifications List   Scheduling Scheduling Request online publishing date: 12/11/2023 10:16 AM (UTC 0 hours)   Due datetime for receiving replies: 12/14/2023 6:00 PM (UTC 0 hours)   Financial Settings Financial Settings Define Advance Payments? No   Define Warranties? No   Contract Documents Contract Documents Document Name Description Doc Classification Anexo II.xlsx Anexo II.xlsx Download CONVITE 2024.doc.pdf CONVITE 2024.doc.pdf Download Caderno de Encargos 2024.doc Caderno de Encargos 2024.doc Download Object of contract This contract is subject to renewal? No   The procurement is related to a project and/or programme financed by European Union funds? No   Legal, economic, financial and technical information The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons? No   Questionnaire Questionnaire     1   Questionário   1.1         Main Section   1.1.1         Articulado * (Os valores indicados não incluem o IVA) Solicitou requisitos adicionais nesta lista de preços.           Preço Total Total without VAT0,000000 EUR             Cód. Artigo Referência Interna Descrição Qt Unidade Preço Unitário Preço Total           Reference1 DescriptionAQUISIÇÃO DE MEDICAMENTOS EXCLUSIVOS DA EMPRESA SANOFI PRODUTOS FARMACEUTICOS, S.A 2024           Reference1 Internal Reference DescriptionETAMBUTOL 400 MG COMP Qty675,000000 UnitCOMP Price per Unit Total           Reference2 Internal Reference DescriptionISONIAZIDA 150 MG + rifamPIcina 300 MG COMP Qty225,000000 UnitCOMP Price per Unit Total           Reference3 Internal Reference DescriptionPIRAZINAMIDA 500 MG CAPS Qty650,000000 UnitCAPS Price per Unit Total           Reference4 Internal Reference DescriptionrifamPIcina 20 MG/ML SUSP ORAL FR 60 ML Qty8,000000 UnitFR Price per Unit Total           Reference5 Internal Reference DescriptionrifamPIcina 300 MG CAPS Qty500,000000 UnitCAPS Price per Unit Total           Reference6 Internal Reference Descriptionrifamicina 250 MG/3 ML SOL INJ FR 3 ML IM Qty417,000000 UnitFR Price per Unit Total           Reference7 Internal Reference DescriptionVIGABATRINA 500 MG COMP Qty60,000000 UnitCOMP Price per Unit Total           Reference8 Internal Reference DescriptioncloBAZam 10 MG COMP Qty150,000000 UnitCOMP Price per Unit Total           Reference9 Internal Reference DescriptionMILRINONA 10 MG/10 ML SOL INJ FR 10 ML IV Qty433,000000 UnitFR Price per Unit Total           Reference10 Internal Reference DescriptionADENOSINA 3 MG/ML SOL INJ FR 10 ML IV Qty417,000000 UnitFR Price per Unit Total           Reference11 Internal Reference DescriptionHIDROCORTISONA 10 MG COMP Qty333,000000 UnitCOMP Price per Unit Total           Reference12 Internal Reference DescriptionHILANO A + HILANO B 8 MG/ML SOL INJ SER 6 ML IARTICULAR Qty17,000000 UnitSER Price per Unit Total           Reference13 Internal Reference DescriptionDUPIlumab 200 MG/1.14 ML SOL INJ CANETA 1.14 ML SC Qty42,000000 UnitCANETA Price per Unit Total           Reference14 Internal Reference DescriptionDUPIlumab 300 MG/2 ML SOL INJ CANETA 2 ML SC Qty383,000000 UnitCANETA Price per Unit Total           Reference15 Internal Reference DescriptionISATuximab 20 MG/ML SOL INJ FR 25 ML IV Qty1,000000 UnitFR Price per Unit Total           Reference16 Internal Reference DescriptionISATuximab 20 MG/ML SOL INJ FR 5 ML IV Qty2,000000 UnitFR Price per Unit Total Evaluation Evaluation Evaluation General Settings Evaluation General Settings Evaluation guideline LowestPrice   Evaluation Method Automatic_Semi_Automatic   Evaluation Items Evaluation Items Name Lot Critérios De Avaliação   Critérios de Adjudicação     Peso (%)** Escala da Avaliação   1   Preço (Tipo de Dados: Preço) Allow manual intervention on evaluation? YesNo Variable Name Description Value Minimum price of all proposals Reply with the lowest price of all qualified replies Price in analysis Price in analysis 100 Fórmula:Min(Pi)   Define tie breaking rules? YesNo     Public Messages Public Messages Type Reference Subject Date No items found...